Skip to main content

Posts

Featured

Global Leaders in Pharmaceutical Research to Headline InnoPharm 2026 in Boston

Hybrid conference to feature renowned experts from Harvard, Stanford, Yale, UC San Diego, NIH, and other leading institutions.  The Second International Conference on Innovations in Pharma R&D (InnoPharm 2026) is set to bring together an outstanding lineup of internationally recognized scientists, clinicians, and innovators from November 2–4, 2026 , at the Holiday Inn Boston Hotel, Massachusetts, USA . Hosted in a hybrid format , the conference will welcome participants both in person and virtually, fostering global collaboration across academia, industry, healthcare, and regulatory science. This year's plenary and keynote program features distinguished researchers from some of the world's most prestigious institutions, including: Donald E. Ingber , Founding Director & Core Faculty, Wyss Institute at Harvard University Daria Mochly-Rosen , Stanford University Martin Schwartz , Yale School of Medicine A. Thomas Look , Dana-Farber Cancer Institute, Harvard Medi...

Latest Posts

InnoPharm Announces the Release of Its Tentative Scientific Program

Poster Presentation Slots Now Open for InnoPharm-2026: Showcase Your Research and Compete for the Best Poster Award

Four Months to Go: InnoPharm-2026 to Bring Global Pharma Leaders to Boston

InnoPharm-2026 Continues to Gain Momentum with Rising Speaker Participation

World-Renowned Cancer Researcher Dr. A. Thomas Look Announced as Keynote Speaker for InnoPharm-2026

5 Months to Go: InnoPharm-2026 Prepares to Bring Global Pharma R&D Leaders to Boston

Second International Conference on Innovations in Pharma R&D Opens Mid-Term Registration for 2026

Early-Bird Registration for InnoPharm-2026 Closes Today

InnoPharm-2026 Announces World-Class Plenary & Keynote Speaker Lineup

Missed his talk last year? Here’s another opportunity to hear from him- Paul Insel, Distinguished Professor at the University of California San Diego, back as a Plenary Speaker at InnoPharm-2026.